Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days
Completed
- Conditions
- Lung Neoplasms
- Registration Number
- NCT01413737
- Lead Sponsor
- Norwegian University of Science and Technology
- Brief Summary
This is a retrospective, descriptive analysis of (1) 30 day postoperative results of surgery for lung cancer, (2) 30 day outcome predictors - compared to an earlier similar study in the same hospital (St Olav University Hospital, Trondheim, Norway).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 148
Inclusion Criteria
- Lung cancer patients after surgery in 2002-2004 at dept for Heart and Lung Surgery, St.Olavs University Hospital, Trondheim, Norway.
Exclusion Criteria
- Carcinoid tumor, small-cell lung cancer, lung metastases
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the 30-day postoperative outcome predictors for lung cancer surgery at St Olav University Hospital?
How does the 30-day mortality rate in NCT01413737 compare to standard lobectomy procedures for non-small cell lung cancer?
What biomarkers correlate with improved 30-day recovery after pulmonary resection for squamous cell lung carcinoma?
Are there specific adverse events associated with wedge resection versus lobectomy in early-stage lung cancer patients?
What are the long-term survival implications of 30-day postoperative complications in lung cancer surgical trials?
Trial Locations
- Locations (1)
NTNU
🇳🇴Trondheim, Norway
NTNU🇳🇴Trondheim, Norway